Singapore Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Singaporean pharmaceuticals market had total revenues of $12.9 billion in 2022, representing a compound annual growth rate (CAGR) of 2.5% between 2017 and 2022.
0
The Singaporean market acquired a 3% share of the Asia-Pacific pharmaceuticals market in 2022. Singapore, a leading biomedical and pharmaceutical hub in Asia, has been attracting foreign and private investors through its Biomedical Sciences initiative since 2000. The government's support, including funding research and development, has also contributed to the industry's growth.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the Singapore pharmaceuticals market by value in 2022?
What will be the size of the Singapore pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in Singapore's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?

8 Company Profiles

8.1. Novartis AG
8.2. Pfizer Inc.
8.3. GSK plc.
8.4. Astellas Pharma Inc.

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Singapore pharmaceuticals market value: $ billion, 2017-22
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Novartis AG: key facts
Table 5: Novartis AG: Annual Financial Ratios
Table 6: Novartis AG: Key Employees
Table 7: Novartis AG: Key Employees Continued
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: Annual Financial Ratios
Table 10: Pfizer Inc.: Key Employees
Table 11: Pfizer Inc.: Key Employees Continued
Table 12: GSK plc.: key facts
Table 13: GSK plc.: Annual Financial Ratios
Table 14: GSK plc.: Key Employees
Table 15: GSK plc.: Key Employees Continued
Table 16: Astellas Pharma Inc.: key facts
Table 17: Astellas Pharma Inc.: Annual Financial Ratios
Table 18: Astellas Pharma Inc.: Key Employees
Table 19: Singapore size of population (million), 2018-22
Table 20: Singapore gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Singapore gdp (current prices, $ billion), 2018-22
Table 22: Singapore inflation, 2018-22
Table 23: Singapore consumer price index (absolute), 2018-22
Table 24: Singapore exchange rate, 2018-22

List of Figures

Figure 1: Singapore pharmaceuticals market value: $ billion, 2017-22
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Novartis AG
Pfizer Inc.
GSK plc.
Astellas Pharma Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€346EUR$350USD£289GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€518EUR$525USD£433GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€691EUR$700USD£577GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Forecast 2024-2030

Pruritus Therapeutics Market by Therapy, Disease Indication, Distribution Channel, Route of Administration - Global Forecast 2025-2030

Pharmaceuticals Global Industry Almanac 2019-2028

Cell Therapy Collaboration and Licensing Deals 2016-2024

Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024